Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Set securing the injection site of an elastomeric pump with Qimo Female and the distal end of its extension tube with Qimo Male. QimoPrime is used to prime the extension tube fitted with Qimo Male.
QimoPrime is a priming device which can be connected to any product fitted with Qimo Male. See corresponding technical file code 7210.81.
Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See corresponding technical file code 7210.91.
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device for blood sampling, intermittent injections or continuous infusions of fluids or drugs.